Baseline infiltration of CD8+T cells or NK cells did not correlate with overall survival (p=0.8133 and p=0.3832, figure 2D), suggesting that baseline tumor infiltration by lymphocytes is not relevant for TILT-123 therapy (as opposed to what has been proposed for ICIs). The gene discussed is CD8A; the disease is neoplasm.